Login to Your Account



Washington Roundup

FDA Issues Draft Guidances on Drug Errors, Bioequivalence

By Staff Reports


Monday, December 17, 2012
The FDA has issued a draft guidance: "Safety Considerations for Product Design to Minimize Medication Errors" that provides drug sponsors with a set of principles for developing drug products using a systems approach to minimize medication errors relating to product design.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription